Avalo Therapeutics, Inc. Common Stock

AVTX US05338F2074

💰
Capitalization
Small-cap

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

🔗
Website
https://www.avalotx.com
Annual Performance 1
2021 2022 2023 2024 2025
-36% -77% -99% -15% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
2
🙍
Insiders
1
Person Price Shares Total Published Completed
Almenoff June Sherie
 13.00
USD 		500
Bought 		6,500
USD 		12/11/2024 13/11/2024
Almenoff June Sherie
 12.50
USD 		500
Bought 		6,250
USD 		12/11/2024 12/11/2024
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Avalo Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-27% -43% 42% -99% -100% -100% -100%
Last 52W Low 52W High All-Time Low All-Time High β
13.48 3.59 14.44 3.59 20,793.60
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Almenoff June Sherie 2 12,749.50 6,374.75 12/11/2024 13/11/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.